Research Review

Highlights include: Real-life safety and efficacy of autologous SCT in elderly MM Lenalidomide maintenance vs. observation for newly diagnosed MM...

Research Review Multiple Myeloma Summit Highlights include:  High risk MM outcomes 5-year results for CyBorD MRD for guiding myeloma treatment...

Issue 28 of Multiple Myeloma Research Review. Highlights include:  Elotuzumab monotherapy for smouldering MM Thereapetuc vulnerability of MM to...

Issue 26 of Multiple Myeloma Research Review. Highlights include:  Selinexor in relapsed/refractory multiple myeloma HIV antivirals overcome...

ANZMAP Multiple Myeloma Highlights from ASH 2017 This publication provides summaries of key clinically relevant multiple myeloma data presented at...

Issue 25 of Multiple Myeloma Research Review.   Highlights include: Induction VCD. Prediction of outcome in newly diagnosed myeloma Final...

Issue 24 of Multiple Myeloma Research Review.   Highlights include: Is MRD the best predictor of response? ctDNA and risk of distant relapse....

Issue 23 of Multiple Myeloma Research Review.   Highlights include: • Revised Myeloma Comorbidity index for multiple myeloma prognosis. •...

This publication is a summary of selected presentations delivered at the Haematology Society of Australia and New Zealand (HSANZ) Inaugural...

Issue 22 of Multiple Myeloma Research Review. Highlights include: •   Benefits of low dose lenalidomide in relapsed/refractory MM. •   Network...

This latest report is a study published in the British Journal of Haematology comparing whole-body ultra-low dose CT (WBULDCT) with spinal MRI...